Previous Close | 13.50 |
Open | 13.90 |
Bid | 10.20 |
Ask | 11.10 |
Strike | 270.00 |
Expire Date | 2024-08-16 |
Day's Range | 13.30 - 13.90 |
Contract Range | N/A |
Volume | |
Open Interest | 41 |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.